The most common method adopted by sponsors and CROs to plan for patient recruitment is to use the research sites’ existing databases of patients. Sites will have suggested how many patients they think they can recruit and will then search through their patient records to cross check the detail against the Inclusion/Exclusion criteria for the trial.

This kind of chart review process is often laborious and time-consuming – in particular with increasingly-complex protocols being the norm for most trials, so it’s good to see various tools that have been developed in the last few years to help speed up this process. Though there will inevitably be some kind of data standardization processing necessary in order to use them successfully.

Some sites will prove most successful at sourcing trial participants – with a large number of sites providing just one or no patients at all.

You may also like

Biotech C-suites Should keep Patient Recruitment in Mind from the Outset
In biotech, a strong C-suite isn’t just about job titles - it’s about covering every part of the journey from discovery to delivery. Including being prepared to tackle one of the biggest ...
Key C-suite Roles for Biotech Success - The Chief Patient Recruitment Officer (CPRO)
While biotech companies have built C-suites with scientific, medical, financial, operational, and business expertise, a critical function has remained conspicuously absent - addressing one ...
Key C-suite Roles for Biotech Success - The Chief Business Officer (CBO)
The Chief Business Officer leads external strategy - licensing deals, identifying pharma partnerships, and developing long-term growth planning and market positioning strategies that ...